These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1107282)

  • 1. N-acylated derivatives of a peptide obtained by enzymatic degradation of pepstatins.
    Matsushita Y; Tone H; Hori S; Yagi Y; Takamatsu A
    J Antibiot (Tokyo); 1975 Dec; 28(12):1016-8. PubMed ID: 1107282
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological activity of pepstatins, pepstanone A and partial peptides on pepsin, cathepsin D and renin.
    Aoyagi T; Morishima H; Nishizawa R; Kunimoto S; Takeuchi T
    J Antibiot (Tokyo); 1972 Dec; 25(12):689-94. PubMed ID: 4568691
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: New pepstatins, pepstatins Bu, Pr and Ac produced by Streptomyces.
    Aoyagi T; Yagisawa Y; Kumagai M; Hamada M; Morishima H
    J Antibiot (Tokyo); 1973 Sep; 26(9):539-41. PubMed ID: 4600212
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of analogues of the carboxyl protease inhibitor pepstatin. Effects of structure on inhibition of pepsin and renin.
    Rich DH; Sun ET; Ulm E
    J Med Chem; 1980 Jan; 23(1):27-33. PubMed ID: 6767029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of dideoxy-pepstatin. Mechanism of inhibition of porcine pepsin.
    Rich DH; Sun E; Singh J
    Biochem Biophys Res Commun; 1977 Jan; 74(2):762-7. PubMed ID: 319803
    [No Abstract]   [Full Text] [Related]  

  • 6. Renin inhibitors containing 2-substituted statine.
    Veber DF; Bock MG; Brady SF; Ulm EH; Cochran DW; Smith GM; LaMont BI; Dipardo RM; Poe M; Freidinger RM
    Biochem Soc Trans; 1984 Dec; 12(6):956-9. PubMed ID: 6442237
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis of analogues of pepstatin. Effect of structure in subsites P1', P2', and P2 on inhibition of porcine pepsin.
    Rich DH; Salituro FG
    J Med Chem; 1983 Jun; 26(6):904-10. PubMed ID: 6406670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of lactoyl-pepstatin and the pepsin inhibitor peptide on pig cathepsin D.
    Kay J; Afting EG; Aoyagi T; Dunn BM
    Biochem J; 1982 Jun; 203(3):795-7. PubMed ID: 7115318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of novel semi-synthetic tight binding inhibitors of pepsin.
    Huddy SP; Patel G; Heywood GC; Austen BM; Hermon-Taylor J
    Biochem Soc Trans; 1989 Dec; 17(6):1124-5. PubMed ID: 2516823
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and antipepsin activities of peptides having a valine or valylvaline moiety at the N-terminus.
    Okada K; Kurosawa Y; Nagai S
    Chem Pharm Bull (Tokyo); 1979 Sep; 27(9):2163-70. PubMed ID: 391419
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological activity of aspartic proteinase inhibitors related to pepstatin.
    Gunn JM; Owens RA; Liu WS; Glover GI
    Acta Biol Med Ger; 1981; 40(10-11):1547-53. PubMed ID: 6805191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valaminols, probably the most simplified peptide-analogs acting as pepsin inhibitors.
    Kratzel M; Bernkop-Schnürch A
    Peptides; 2000 Feb; 21(2):289-93. PubMed ID: 10764958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of analogues of the carboxyl protease inhibitor pepstatin. Effect of structure in subsite P3 on inhibition of pepsin.
    Rich DH; Bernatowicz MS
    J Med Chem; 1982 Jul; 25(7):791-5. PubMed ID: 6809942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of inhibition of pepsin by pepstatin. Effect of inhibitor structure on dissociation constant and time-dependent inhibition.
    Rich DH; Sun ET
    Biochem Pharmacol; 1980 Aug; 29(16):2205-12. PubMed ID: 6775634
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Hydroxypepstatin, a new peptatin produced by Streptomyces.
    Umezawa H; Miyano T; Murakami T; Takita T; Aoyagi T
    J Antibiot (Tokyo); 1973 Oct; 26(10):615-7. PubMed ID: 4599524
    [No Abstract]   [Full Text] [Related]  

  • 16. Solid-phase synthesis of a soluble pepstatin derivative suitable for therapeutic use.
    Austen BM; Ford TF; Grant DA; Hermon-Taylor J
    Biosci Rep; 1982 Jun; 2(6):427-32. PubMed ID: 6809068
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthetic and enzyme inhibition studies of pepstatin analogues containing hydroxyethylene and ketomethylene dipeptide isosteres.
    Holladay MW; Salituro FG; Rich DH
    J Med Chem; 1987 Feb; 30(2):374-83. PubMed ID: 3100803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ahpatinins, new acid protease inhibitors containing 4-amino-3-hydroxy-5-phenylpentanoic acid.
    Omura S; Imamura N; Kawakita K; Mori Y; Yamazaki Y; Masuma R; Takahashi Y; Tanaka H; Huang LY; Woodruff HB
    J Antibiot (Tokyo); 1986 Aug; 39(8):1079-85. PubMed ID: 3093433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of all the stereoisomers of statine (4-amino-3-hydroxy-6-methylheptanoic acid). Inhibition of pepsin activity by N-carbobenzoxy-L-valyl-L-valyl-statine derived from the four stereoisomers.
    Liu WS; Smith SC; Glover GI
    J Med Chem; 1979 May; 22(5):577-9. PubMed ID: 379333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Effect of a pepsin-inhibitory pentapeptide upon the gastric secretion of pepsin and hydrochloric acid.
    Christiansen PM; Svendsen LB; Guldager N; Christensen L
    Gut; 1975 Oct; 16(10):823-4. PubMed ID: 1107170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.